Table 1 Clinical features of hyalinizing clear cell carcinomas of bronchial (a) and salivary (b) origin, and previous reported cases (c)

From: Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas

a. Bronchial gland origin

      

Case

Age

Gender

Smoking (cigarettes per day × years)

Location

Maximum tumor size

Relapse-free survival (months)

B1

52

F

Non-smoker

Right, segmental bronchus (lower lobe, between B9 and B10)

33 mm

181

B2

35

F

15 × 20

Right, secondary bronchus (lower to middle lobar bronchus)

28 mm

79

B3

56

F

Non-smoker

Right, secondary bronchus (lower to inferior lobar bronchus)

33 mm

12

b. Salivary gland origin

       

Case

Age

Gender

Smoking (cigarettes per day × years)

Location

Chemoradiation therapy before resection

Maximum tumor size

Relapse-free survival (months)

S1

44

F

10 × 15

Mesopharynx, anterior

66 Gy + CDDP

25 mm

81

S2

80

F

Non-smoker

Mesopharynx, anterior

None

35 mm

12

S3

64

M

20 × 40

Buccal mucosa, left

None

25 mm

14

c. Bronchial gland origin, previous reports

       

Case

Reference

Age

Gender

Smoking

Location

Maximum tumor size

Relapse-free survival (months)

R1

Garcia JJ, et al [14]

38

M

Non-smoker

Right, perihilar mass

30.3 mm

ND

R2

Shah AA, et al [13]

32

M

Non-smoker

Left, segmental bronchus

18 mm

ND

R3

Shah AA, et al [13]

39

M

Non-smoker

Right, bronchial wall

26 mm

ND

R4

Wang H, et al [15]

53

M

Non-smoker

Right, upper lobe

ND

192

R5

Shahi M, et al [16]

55

M

aEx-smoker

Right, middle lobe

25 mm

20

R6

Jeffus SK, et al [17]

54

F

Ex-light-smokerb

Left, upper lobe

32 mm

16

  1. Gy gray, CDDP cis-diamminedichloroplatinum
  2. aDetails are unknown
  3. bLess than one pack per week × 3 years